ATE234623T1 - Zusammensetzung welche einen darmbakterienstamm und glutamin enthält - Google Patents

Zusammensetzung welche einen darmbakterienstamm und glutamin enthält

Info

Publication number: ATE234623T1
Authority: AT; Austria
Prior art keywords: pct; glutamine; strain; composition containing; intestinal bacteria
Prior art date: 1995-06-23

Application number

AT96922842T

Other languages

English (en)

Inventor

Haen Christoph De

Luigia Gozzini

Original Assignee

Bracco Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-23

Filing date

1996-06-19

Publication date

2003-04-15

1996-06-19 Application filed by Bracco Spa filed Critical Bracco Spa

2003-04-15 Application granted granted Critical

2003-04-15 Publication of ATE234623T1 publication Critical patent/ATE234623T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
241000894006 Bacteria Species 0.000 title 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 title 1
230000000968 intestinal effect Effects 0.000 title 1
208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
230000037213 diet Effects 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Mycology (AREA)
Chemical & Material Sciences (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Seasonings (AREA)
Confectionery (AREA)
Non-Alcoholic Beverages (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

AT96922842T 1995-06-23 1996-06-19 Zusammensetzung welche einen darmbakterienstamm und glutamin enthält ATE234623T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT95MI001359A IT1276783B1 (it)	1995-06-23	1995-06-23	Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
PCT/EP1996/002650 WO1997000688A1 (en)	1995-06-23	1996-06-19	Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders

Publications (1)

Publication Number	Publication Date
ATE234623T1 true ATE234623T1 (de)	2003-04-15

Family

ID=11371866

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96922842T ATE234623T1 (de)	1995-06-23	1996-06-19	Zusammensetzung welche einen darmbakterienstamm und glutamin enthält

Country Status (18)

Country	Link
US (1)	US6007808A (de)
EP (1)	EP0833644B1 (de)
JP (1)	JPH11507934A (de)
CN (1)	CN1082373C (de)
AT (1)	ATE234623T1 (de)
AU (1)	AU707399B2 (de)
BR (1)	BR9609413A (de)
CA (1)	CA2219739A1 (de)
DE (2)	DE833644T1 (de)
DK (1)	DK0833644T3 (de)
ES (1)	ES2194107T3 (de)
HU (1)	HUP9901707A3 (de)
IT (1)	IT1276783B1 (de)
MX (1)	MX9709238A (de)
NO (1)	NO976048L (de)
NZ (1)	NZ312121A (de)
WO (1)	WO1997000688A1 (de)
ZA (1)	ZA965235B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020035071A1 (en) *	1997-07-08	2002-03-21	Josef Pitha	Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en)	1997-07-08	2013-10-22	The Iams Company	Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) *	1997-07-08	2006-06-01	The Iams Company	Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US6641808B1 (en)	1999-09-22	2003-11-04	Lacpro Industries, Llc	Composition for treatment of obesity
US20040166101A1 (en) *	1999-09-22	2004-08-26	Bojrab Gregory G.	Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
WO2001083700A2 (en) *	2000-05-03	2001-11-08	University Of Maryland, Baltimore	Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal
US7112570B2 (en) *	2000-08-24	2006-09-26	Neuren Pharmaceuticals, Ltd.	GPE analogs
CA2439293A1 (en)	2001-03-05	2002-09-12	Stephen P. Ernest	Enteral formulation
TWI351278B (en) *	2002-03-01	2011-11-01	Nisshin Pharma Inc	Agent for preventing and treating of liver disease
JP4559380B2 (ja) *	2002-03-01	2010-10-06	日清ファルマ株式会社	肝疾患治療剤
DE60326049D1 (de) *	2002-07-22	2009-03-19	Meito Sangyo Kk	Zusammensetzung zur förderung der vermehrung von lactobacillus casei subsp. casei
DK175877B1 (da) *	2002-11-11	2005-05-09	Pharmalett As	Præparater til anvendelse som terapeutisk middel
US7384628B2 (en) *	2003-06-23	2008-06-10	Agtech Products, Inc.	Lactic acid bacteria and its use in direct-fed microbials
US20050100559A1 (en) *	2003-11-07	2005-05-12	The Procter & Gamble Company	Stabilized compositions comprising a probiotic
US8894991B2 (en) *	2003-12-19	2014-11-25	The Iams Company	Canine probiotic Lactobacilli
US20050158294A1 (en) *	2003-12-19	2005-07-21	The Procter & Gamble Company	Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en)	2003-12-19	2014-11-04	The Iams Company	Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en)	2003-12-19	2010-08-31	The Procter & Gamble Company	Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) *	2003-12-19	2005-07-14	The Procter & Gamble Company	Canine probiotic Bifidobacteria globosum
EP2261323A1 (de) *	2005-05-31	2010-12-15	The Iams Company	Probiotische Katzen-Laktobazillen
AU2006253007B2 (en) *	2005-05-31	2012-12-20	Alimentary Health Ltd	Feline probiotic Bifidobacteria
WO2007119502A1 (ja) *	2006-03-23	2007-10-25	Kyowa Hakko Kogyo Co., Ltd.	便通改善剤
US20100316769A1 (en) *	2006-03-29	2010-12-16	Gail Czarnecki-Maulden	Dietary supplements containing probiotics
RU2436581C2 (ru)	2007-02-01	2011-12-20	Дзе Иамс Компани	Способ уменьшения воспаления и снижения стресса у млекопитающего
CN101259140B (zh) *	2007-03-08	2012-08-22	重庆北碚现代应用药物研究所	一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
CN101273737B (zh) *	2007-03-28	2011-08-24	哈尔滨正方科技有限公司	一种在常温下保持高活菌数的发酵乳饮料的制备方法
US9771199B2 (en)	2008-07-07	2017-09-26	Mars, Incorporated	Probiotic supplement, process for making, and packaging
EP2206506A1 (de) *	2008-12-18	2010-07-14	Bracco Imaging S.p.A	Probiotische Formulierungen
WO2011009848A2 (en)	2009-07-20	2011-01-27	Bracco Spa	Therapeutic use of probiotics
US10104903B2 (en)	2009-07-31	2018-10-23	Mars, Incorporated	Animal food and its appearance
WO2013099883A1 (ja)	2011-12-28	2013-07-04	株式会社山田養蜂場本社	IgA産生促進作用を有する新規乳酸菌及びその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839281A (en) *	1985-04-17	1989-06-13	New England Medical Center Hospitals, Inc.	Lactobacillus strains and methods of selection
US5397803A (en) *	1985-09-12	1995-03-14	Brigham And Women's Hospital	Use of glutamine to reduce rate of pathogenic microorganism infection
JPH0367046A (ja) *	1989-08-05	1991-03-22	Mitsubishi Motors Corp	エンジンの吸入空気量制御装置
CN1105544A (zh) *	1994-09-09	1995-07-26	扬州大学农学院	一种制取活性乳酸菌口服液的方法
US5531681A (en) *	1995-01-13	1996-07-02	Abbott Laboratories	Apparatus for altering composition of nutritional product during enteral tube feeding

1995
- 1995-06-23 IT IT95MI001359A patent/IT1276783B1/it active IP Right Grant
1996
- 1996-06-19 ES ES96922842T patent/ES2194107T3/es not_active Expired - Lifetime
- 1996-06-19 CN CN96194976A patent/CN1082373C/zh not_active Expired - Fee Related
- 1996-06-19 HU HU9901707A patent/HUP9901707A3/hu unknown
- 1996-06-19 WO PCT/EP1996/002650 patent/WO1997000688A1/en not_active Ceased
- 1996-06-19 DK DK96922842T patent/DK0833644T3/da active
- 1996-06-19 EP EP96922842A patent/EP0833644B1/de not_active Expired - Lifetime
- 1996-06-19 DE DE0833644T patent/DE833644T1/de active Pending
- 1996-06-19 CA CA002219739A patent/CA2219739A1/en not_active Abandoned
- 1996-06-19 AT AT96922842T patent/ATE234623T1/de not_active IP Right Cessation
- 1996-06-19 US US08/973,676 patent/US6007808A/en not_active Expired - Lifetime
- 1996-06-19 NZ NZ312121A patent/NZ312121A/xx unknown
- 1996-06-19 BR BR9609413A patent/BR9609413A/pt not_active Application Discontinuation
- 1996-06-19 AU AU63575/96A patent/AU707399B2/en not_active Ceased
- 1996-06-19 DE DE69626818T patent/DE69626818T2/de not_active Expired - Lifetime
- 1996-06-19 MX MX9709238A patent/MX9709238A/es not_active IP Right Cessation
- 1996-06-19 JP JP9503576A patent/JPH11507934A/ja active Pending
- 1996-06-20 ZA ZA965235A patent/ZA965235B/xx unknown
1997
- 1997-12-22 NO NO976048A patent/NO976048L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU6357596A (en)	1997-01-22
WO1997000688A1 (en)	1997-01-09
ITMI951359A1 (it)	1996-12-23
US6007808A (en)	1999-12-28
BR9609413A (pt)	1999-05-18
NO976048D0 (no)	1997-12-22
HUP9901707A3 (en)	2001-04-28
MX9709238A (es)	1998-03-31
IT1276783B1 (it)	1997-11-03
NZ312121A (en)	1999-03-29
EP0833644B1 (de)	2003-03-19
DK0833644T3 (da)	2003-07-21
JPH11507934A (ja)	1999-07-13
EP0833644A1 (de)	1998-04-08
CN1082373C (zh)	2002-04-10
DE69626818T2 (de)	2003-11-20
NO976048L (no)	1998-02-23
CA2219739A1 (en)	1997-01-09
CN1188413A (zh)	1998-07-22
ES2194107T3 (es)	2003-11-16
DE69626818D1 (de)	2003-04-24
ZA965235B (en)	1997-01-09
DE833644T1 (de)	1998-09-03
HUP9901707A2 (hu)	1999-09-28
AU707399B2 (en)	1999-07-08
ITMI951359A0 (it)	1995-06-23

Legal Events

Date

Code

Title

Description

2003-10-15

UEP

Publication of translation of european patent specification

Ref document number: 0833644

Country of ref document: EP

2005-03-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE234623T1 (de)	2003-04-15	Zusammensetzung welche einen darmbakterienstamm und glutamin enthält
NO306346B1 (no)	1999-10-25	N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat
IL111077A (en)	1999-10-28	Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
MX9604378A (es)	1997-03-29	Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
HUT72436A (en)	1996-04-29	Process for the production of imidazopyridines and pharmaceutical compositions containing them and which are suitable for treating gastro-intestinal diseases
IL123002A0 (en)	1998-08-16	1-Phenyl-2- phenylacetoxy- ethanone derivatives
IL113941A (en)	2000-02-17	Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them
ATE200672T1 (de)	2001-05-15	Alkoxyalkylcarbamate von imidazo(1,2-a)pyridinen
AU4623396A (en)	1996-09-11	1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
DK0748314T3 (da)	2002-08-26	Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
BR9609847A (pt)	1999-03-09	Derivados de N-(4-Benzila-substituída)-2-aminolactam
DK0711283T3 (da)	1999-11-22	Tetrahydro-1H-benzazepinoner og hexahydroazepinoner som selektive cholecystokinin-B-receptorantagonister
NO306400B1 (no)	1999-11-01	N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
AU5819394A (en)	1994-08-15	N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
NZ320522A (en)	1999-03-29	Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
ES2137665T3 (es)	1999-12-16	Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
TR199902564T2 (xx)	2000-02-21	K�k�rdak oligomer matris proteininin romatoid artrit tedavisinde kullan�m�.
AU7230894A (en)	1995-02-06	Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
MY138319A (en)	2009-05-29	1,5-benzodiazepine derivatives
ATE170527T1 (de)	1998-09-15	Phosphonobernsteinsäurederivate und ihre verwendung als arzneimittel
AU5768298A (en)	1998-07-17	Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
MX9804579A (es)	1998-10-31	Composiciones que contienen bismuto para la prevencion y tratamiento de trastornos gastrointestinales.